Semax, an analog of ACTH(4-7), regulates expression of immune response genes during ischemic brain injury in rats
The DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index.
Abstract
Brain stroke continues to claim the lives of million people every year. To build the effective strategies for stroke treatment it is necessary to understand the neuroprotective mechanisms that are able to prevent the ischemic injury. Consisting of the ACTH (4-7) fragment and the tripeptide Pro-Gly-Pro (PGP), the synthetic peptide Semax effectively protects brain against ischemic stroke. However, the molecular mechanisms underlying its neuroprotection and participation of PGP in them are still needed to be clarified. To reveal biological processes and signaling pathways, which are affected by Semax and PGP, we performed the transcriptome analysis of cerebral cortex of rats with focal cerebral ischemia treated by these peptides. The genome-wide biochip data analysis detected the differentially expressed genes (DEGs) and bioinformatic web-tool Ingenuity iReport found DEGs associations with several biological processes and signaling pathways. The immune response is the process most markedly affected by the peptide: Semax enhances antigen presentation signaling pathway, intensifies the effect of ischemia on the interferon signaling pathways and affects the processes for synthesizing immunoglobulins. Semax significantly increased expression of the gene encoding the immunoglobulin heavy chain, highly affects on cytokine, stress response and ribosomal protein-encoding genes after occlusion. PGP treatment of rats with ischemia attenuates the immune activity and suppresses neurotransmi…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“significantly affects the expression of genes associated with the processes of the immune response [15,16]”
From Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4–7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia–Reperfusion (2021) · cites this paper as [16]
In the citing paper
“It has been shown that Semax decreases ischemic brain damage in clinical and animal studies by inducing the expression of neurotrophins and their receptors [45,46,47,48,49,50].”
From Protective Effects of PGC-1α Activators on Ischemic Stroke in a Rat Model of Photochemically Induced Thrombosis (2021) · cites this paper as [50]
In the citing paper
“Using microchips RatRef-12 BeadChips, it was shown that peptide Semax affects the expression of genes related to the immune and vascular systems in rat fronto-parietal cortex after permanent middle cerebral artery occlusion (pMCAO) [26,27].”
From Novel Insights into the Protective Properties of ACTH(4-7)PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia-Reperfusion in Rats (2020) · cites this paper as [27]
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Pfaffl, M. W. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.9.e36 · Cited by 7,376
Thresholds in cerebral ischemia - the ischemic penumbra.
Astrup, J., Siesjö, B. K., & Symon, L. (1981) · Stroke · doi:10.1161/01.str.12.6.723 · Cited by 2,820
IRF-7 is the master regulator of type-I interferon-dependent immune responses
Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N., Ohba, Y., Takaoka, A., Yoshida, N., et al. (2005) · Nature · doi:10.1038/nature03464 · Cited by 2,245
Intravenous immunoglobulin therapy: how does IgG modulate the immune system?
Schwab, I., & Nimmerjahn, F. (2013) · Nature Reviews Immunology · doi:10.1038/nri3401 · Cited by 820
Ribosomal proteins: functions beyond the ribosome
Zhou, X., Liao, W.-J., Liao, J.-M., Liao, P., & Lu, H. (2015) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjv014 · Cited by 743
Molecular Cloning and Functional Expression of a New Human CC-Chemokine Receptor Gene
Samson, M., Labbe, O., Mollereau, C., Vassart, G., & Parmentier, M. (1996) · Biochemistry · doi:10.1021/bi952950g · Cited by 686
A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction.
Chen, S. T., Hsu, C. Y., Hogan, E. L., Maricq, H., & Balentine, J. D. (1986) · Stroke · doi:10.1161/01.str.17.4.738 · Cited by 594
Yang-Wei Fann, D., Lee, S.-Y., Manzanero, S., Tang, S.-C., Gelderblom, M., Chunduri, P., Bernreuther, C., Glatzel, M., Cheng, Y.-L., Thundyil, J., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.326 · Cited by 475
Pre-ribosomes on the road from the nucleolus to the cytoplasm
Tschochner, H., & Hurt, E. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00054-0 · Cited by 473
Post‐ischemic brain damage: pathophysiology and role of inflammatory mediators
Amantea, D., Nappi, G., Bernardi, G., Bagetta, G., & Corasaniti, M. T. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06766.x · Cited by 459
Activation of natural regulatory T cells by IgG Fc–derived peptide “Tregitopes”
De Groot, A. S., Moise, L., McMurry, J. A., Wambre, E., Van Overtvelt, L., Moingeon, P., Scott, D. W., & Martin, W. (2008) · Blood · doi:10.1182/blood-2008-02-138073 · Cited by 392
The T Cell Protein Tyrosine Phosphatase Is a Negative Regulator of Janus Family Kinases 1 and 3
Simoncic, P. D., Lee-Loy, A., Barber, D. L., Tremblay, M. L., & McGlade, C. J. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00697-8 · Cited by 351
Uguccioni, M., D'Apuzzo, M., Loetscher, M., Dewald, B., & Baggiolini, M. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250113 · Cited by 346
Ephrem, A., Chamat, S., Miquel, C., Fisson, S., Mouthon, L., Caligiuri, G., Delignat, S., Elluru, S., Bayry, J., Lacroix-Desmazes, S., et al. (2008) · Blood · doi:10.1182/blood-2007-03-079947 · Cited by 292
Figueiredo, H. F., Bruestle, A., Bodie, B., Dolgas, C. M., & Herman, J. P. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02932.x · Cited by 251
Cytoplasmic protein tyrosine phosphatases, regulation and function: the roles of PTP1B and TC-PTP
Bourdeau, A., Dubé, N., & Tremblay, M. L. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.02.001 · Cited by 243
Chang, L.-Y., Lin, Y.-C., Mahalingam, J., Huang, C.-T., Chen, T.-W., Kang, C.-W., Peng, H.-M., Chu, Y.-Y., Chiang, J.-M., Dutta, A., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2493 · Cited by 232
Thompson, W. L., & Van Eldik, L. J. (2009) · Brain Research · doi:10.1016/j.brainres.2009.06.081 · Cited by 211
Arumugam, T. V., Tang, S.-C., Lathia, J. D., Cheng, A., Mughal, M. R., Chigurupati, S., Magnus, T., Chan, S. L., Jo, D.-G., Ouyang, X., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700506104 · Cited by 204
Terao, S., Yilmaz, G., Stokes, K. Y., Russell, J., Ishikawa, M., Kawase, T., & Granger, D. N. (2008) · Stroke · doi:10.1161/strokeaha.107.513150 · Cited by 163
Heat Shock Proteins: Endogenous Modulators of Apoptotic Cell Death
Mirjolet, C., Schmitt, E., Brunet, M., Maingret, L., Parcellier, A., & Garrido, C. (2005) · Springer eBooks · doi:10.1007/3-540-29717-0_8 · Cited by 159
Miotto, D., Christodoulopoulos, P., Olivenstein, R., Taha, R. A., Cameron, L., Tsicopoulos, A., Tonnel, A., Fahy, O., Lafitte, J., Luster, A. D., et al. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.113524 · Cited by 151
CC and CXC chemokines are pivotal mediators of cerebral injury in ischaemic stroke
Viviani, G. L., Dallegri, F., Quercioli, A., Veneselli, E., Mach, F., Mirabelli-Badenier, M., Braunersreuther, V., & Montecucco, F. (2011) · Thrombosis and Haemostasis · doi:10.1160/th10-10-0662 · Cited by 144
Targeting ischemic penumbra Part I: from pathophysiology to therapeutic strategy
Liu, S., Levine, S. R., & Winn, H. R. (2010) · Journal of Experimental Stroke and Translational Medicine · doi:10.6030/1939-067x-3.1.47 · Cited by 137
Veldhuis, W. B., Floris, S., van der Meide, P. H., Vos, I. M. P., de Vries, H. E., Dijkstra, C. D., Bär, P. R., & Nicolay, K. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000080701.47016.24 · Cited by 126
Ribosomal Protein Insufficiency and the Minute Syndrome in Drosophila: A Dose-Response Relationship
Sæbøe-Larssen, S., Lyamouri, M., Merriam, J., Oksvold, M. P., & Lambertsson, A. (1998) · Genetics · doi:10.1093/genetics/148.3.1215 · Cited by 102
Kalaria, R. N., & Ballard, C. G. (2001) · Current Atherosclerosis Reports · doi:10.1007/s11883-001-0028-5 · Cited by 95
The other side of immunoglobulin G: suppressor of inflammation
Aschermann, S., Lux, A., Baerenwaldt, A., Biburger, M., & Nimmerjahn, F. (2010) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.04081.x · Cited by 91
Increased brain damage after ischaemic stroke in mice lacking the chemokine receptor CCR5
Sorce, S., Bonnefont, J., Julien, S., Marq‐Lin, N., Rodríguez, I., Dubois‐Dauphin, M., & Krause, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00697.x · Cited by 85
Injury-Induced Type I IFN Signaling Regulates Inflammatory Responses in the Central Nervous System
Khorooshi, R., & Owens, T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901753 · Cited by 78
CC Chemokine Receptor 5: The Interface of Host Immunity and Cancer
de Oliveira, C. E. C., Oda, J. M. M., Guembarovski, R. L., de Oliveira, K. B., Ariza, C. B., Neto, J. S., Hirata, B. K. B., & Watanabe, M. A. E. (2014) · Disease Markers · doi:10.1155/2014/126954 · Cited by 75
Pharmacologic recruitment of regulatory T cells as a therapy for ischemic acute kidney injury
Lai, L.-W., Yong, K.-C., & Lien, Y.-H. H. (2011) · Kidney International · doi:10.1038/ki.2011.412 · Cited by 72
Intravenous immunoglobulin: a review.
Eibl, M. M., & Wedgwood, R. (1989) · PubMed · Cited by 71
Measurement of MxA mRNA or protein as a biomarker of IFNβ bioactivity
Pachner, A. R., Bertolotto, A., & Deisenhammer, F. (2003) · Neurology · doi:10.1212/01.wnl.0000092361.04511.d0 · Cited by 71
Ubogu, E. E., Callahan, M. K., Tucky, B. H., & Ransohoff, R. M. (2006) · Cellular Immunology · doi:10.1016/j.cellimm.2006.12.001 · Cited by 67
Intravenous immunoglobulin therapy for autoimmune diseases
Arnson, Y., Shoenfeld, Y., & Amital, H. (2009) · Autoimmunity · doi:10.1080/08916930902785363 · Cited by 64
Neuropeptides in learning and memory processes
de Wied, D. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)86050-0 · Cited by 63
HspB1 (Hsp 27) Expression and Neuroprotection in the Retina
O’Reilly, A. M., Currie, R. W., & Clarke, D. B. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8143-3 · Cited by 62
Liu, H., Xin, L., Chan, B. P. L., Teoh, R., Tang, B. L., & Tan, Y. H. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00371-3 · Cited by 62
Wen, X., Kudo, T., Payne, L., Wang, X., Rodgers, L., & Suzuki, Y. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2009.0119 · Cited by 60
Silva, M., de Aguiar, D. C., Diniz, C. R. A. F., Guimarães, F. S., & Joca, S. R. L. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9775-1 · Cited by 57
Dmitrieva, V. G., Povarova, O. V., Skvortsova, V. I., Limborska, S. A., Myasoedov, N. F., & Dergunova, L. V. (2010) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9432-0 · Cited by 54
Self-citationThe IRG proteins: A function in search of a mechanism
Howard, J. C. (2008) · Immunobiology · doi:10.1016/j.imbio.2007.11.005 · Cited by 49
Widiapradja, A., Vegh, V., Lok, K. Z., Manzanero, S., Thundyil, J., Gelderblom, M., Cheng, Y., Pavlovski, D., Tang, S., Jo, D., et al. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07754.x · Cited by 47
Gesuete, R., Packard, A. E. B., Vartanian, K. B., Conrad, V. K., Stevens, S. L., Bahjat, F. R., Yang, T., & Stenzel‐Poore, M. P. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07946.x · Cited by 47
Storozhevykh, T. P., Tukhbatova, G. R., Senilova, Y. E., Pinelis, V. G., Andreeva, L. A., & Myasoyedov, N. F. (2007) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-007-0192-x · Cited by 41
Bashkatova, V. G., Koshelev, V. B., Fadyukova, O. E., Alexeev, A. A., Vanin, A. F., Rayevsky, K. S., Ashmarin, I. P., & Armstrong, D. M. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03324-2 · Cited by 36
Stavchansky, V. V., Yuzhakov, V. V., Botsina, A. Y., Skvortsova, V. I., Bondurko, L. N., Tsyganova, M. G., Limborska, S. A., Myasoedov, N. F., & Dergunova, L. V. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9421-2 · Cited by 34
Self-citationTargeting ischemic brain injury with intravenous immunoglobulin
Arumugam, T. V., Selvaraj, P. K., Woodruff, T. M., & Mattson, M. P. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.1.19 · Cited by 34
Interferon-β Fails to Protect in a Model of Transient Focal Stroke
Maier, C. M., Yu, F., Nishi, T., Lathrop, S. J., & Chan, P. H. (2006) · Stroke · doi:10.1161/01.str.0000208214.46093.d5 · Cited by 33
Medvedeva, E. V., Dmitrieva, V. G., Povarova, O. V., Limborska, S. A., Skvortsova, V. I., Myasoedov, N. F., & Dergunova, L. V. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-228 · Cited by 33
Self-citationShoji, H., & Mizoguchi, K. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.06.005 · Cited by 28
[A nootropic adrenocorticotropin analog 4-10-semax (l5 years experience in its design and study)].
Ip, A., Nezavibat'ko, V. N., Nf, M., et al. (1997) · PubMed · Cited by 28
Dolotov, O. V., Zolotarev, Y. A., Dorokhova, E. M., Андреева, Л. А., Alfeeva, L. Y., Grivennikov, I. A., & Myasoedov, N. F. (2004) · Russian Journal of Bioorganic Chemistry · doi:10.1023/b:rubi.0000030127.46845.f0 · Cited by 20
Self-citationMartynova, K. V., Андреева, Л. А., Климова, П. А., Kirillova, Y. G., Shevchenko, V. P., Nagaev, I. Y., Shram, S. I., Швец, В. И., & Myasoedov, N. F. (2009) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162009020022 · Cited by 19
Self-citationExpression of sphingomyelin synthase 1 gene in rat brain focal ischemia
Dmitrieva, V. G., Torshina, E. V., Yuzhakov, V. V., Povarova, O. V., Skvortsova, V. I., Limborska, S. A., & Dergunova, L. V. (2008) · Brain Research · doi:10.1016/j.brainres.2007.10.056 · Cited by 19
Self-citationDmitrieva, V. G., Dergunova, L. V., Поварова, О. В., Skvortsova, V. I., Limborskaya, S. A., & Myasoedov, N. F. (2008) · Doklady Biochemistry and Biophysics · doi:10.1134/s1607672908050037 · Cited by 16
Self-citationOgata, S., Ogata, A., Schneider-Schaulies, S., et al. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.04.029 · Cited by 16
[Increased resistance to hypoxia effected by the neuropeptide preparation SEMAX].
(1992) · PubMed · Cited by 15
Hong, H., Kim, C., KIM, J.-D., & Seo, J.-H. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2005 · Cited by 14
Evaluation of therapeutic effect of new Russian drug semax in optic nerve disease
Polunin, G. S., Nurieva, S. M., Baiandin, D. L., & Sheremet, N. L. (2000) · PubMed · Cited by 13
Grigorjeva, M., & Lyapina, L. A. (2010) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-010-0871-x · Cited by 8
The effects of intravenous immunoglobulin on cerebral ischemia in rats: An experimental study
Tunik, S., Aluçlu, M. U., Açar, A., Akkoç, H., Güzel, A., Alabalık, U., & Akkuş, M. (2013) · Toxicology and Industrial Health · doi:10.1177/0748233713498461 · Cited by 7
(1996) · doi:10.1002/(sici)1520-6769(199609)19:2<115::aid-nrc171>3.0.co;2-b
Research works printed but not linked: 2
- Ashmarin IP, Nezavibatko VN, Levitskaya NG, Koshelev VB, Kamensky AA 1995 Design and investigation of an ACTH(4–10) analogue lacking d-amino acids and hydrophobic radicals. Neurosci Res Commun 16:105–112.
- Gusev EI, Skvortsova VI (2001) Brain ischaemia, 1st edn. Meditsina Publishers, Moscow
Cited by
Peptide Regulation of Gene Expression: A Systematic Review
Khavinson, V. K., Popovich, I. G., Linkova, N. S., Mironova, E. S., & Ilina, A. (2021) · Molecules · doi:10.3390/molecules26227053 · Cited by 51
“It was shown that this short peptide changes the expression of mRNA for 96 genes associated with the number and mobility of immune cells, the functional activity of chemokines and immunoglobulins, as well as those involved in such processes as the development and migration of endothelial tissue cells, the migration of…”
BackgroundNeuroprotective Peptides and New Strategies for Ischemic Stroke Drug Discoveries
Dergunova, L. V., Filippenkov, I. B., Limborska, S. A., & Myasoedov, N. F. (2023) · Genes · doi:10.3390/genes14050953 · Cited by 40
Self-citationFilippenkov, I. B., Stavchansky, V. V., Denisova, A. E., Yuzhakov, V. V., Sevan’kaeva, L. E., Sudarkina, O. Y., Dmitrieva, V. G., Gubsky, L. V., Myasoedov, N. F., Limborska, S. A., et al. (2020) · Genes · doi:10.3390/genes11060681 · Cited by 29
“Using microchips RatRef-12 BeadChips, it was shown that peptide Semax affects the expression of genes related to the immune and vascular systems in rat fronto-parietal cortex after permanent middle cerebral artery occlusion (pMCAO) [26,27].”
BackgroundMethodInfluentialSelf-citationMitigating Traumatic Brain Injury: A Narrative Review of Supplementation and Dietary Protocols
Conti, F., MCCUE, J., Dituro, P., Galpin, A. J., & Wood, T. R. (2024) · Nutrients · doi:10.3390/nu16152430 · Cited by 40
“Most notably, Dolotov, et al. [204] found that semax administration significantly increases the expression of BDNF in the rat hippocampus, while Medvedeva, et al. [205] demonstrated favourable outcomes of treatment with semax in immune regulation following ischemic brain injury in the same species.”
BackgroundEnkephalins and ACTH in the mammalian nervous system
Duque-Díaz, E., Ojeda, O. M. Á., & Coveñas, R. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.05.001 · Cited by 28
Metadata
- Authors
- Medvedeva, E. V., Dmitrieva, V. G., Limborska, S. A., Myasoedov, N. F., & Dergunova, L. V.
- Affiliations
- Russian Academy of Sciences (RU)
- Corresponding author
- Medvedeva, Ekaterina V.
- Venue
- Molecular Genetics and Genomics
- Published
- 2017-03-02
- Volume
- 292
- Issue
- 3
- Pages
- 635-653
- ISSN
- 1617-4615 (ISSN-L)
- 1617-4623
- OpenAlex
- W2594819773
- Cited by
- 23
- References
- 66
- Citations by year
- 2024: 2 · 2023: 2 · 2022: 4 · 2021: 8 · 2020: 4 · 2019: 3
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Molecular Genetics and Genomics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Russian Foundation for Basic Research (16-34-00760)
- Russian Science Foundation (16-14-00077)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- Semax, focal cerebral ischemia, ischemic stroke, neuroprotection, immune response genes, transcriptome, cerebral cortex, interferon signaling, immunoglobulin heavy chain, cytokines, stress response, ribosomal proteins, neuroimmune interactions, neurotransmission
- MeSH terms
- Adrenocorticotropic Hormone, Animals, Brain Ischemia, Disease Models, Animal, Immunoglobulin Heavy Chains, Male, Oligopeptides, Peptide Fragments, Proline, Stress, Physiological, Rats, Wistar, Antigen Presentation, Neuroprotective Agents, Middle Cerebral Artery, Gene Expression Profiling, Genes, Immunoglobulin Heavy Chain, Rats, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.